Jakavi 5mg Tablet (Ruxolitinib)

Overview:
Jakavi 5mg Tablet is a Janus kinase (JAK) inhibitor that works by blocking JAK1 and JAK2 enzymes, which are overactive in certain blood disorders. It helps reduce abnormal blood cell production, control symptoms, and improve quality of life in patients with myeloproliferative disorders.

Uses:

• Treatment of intermediate or high-risk myelofibrosis.

• Management of polycythemia vera in patients who are resistant or intolerant to hydroxyurea.

• Helps reduce spleen size, control blood counts, and alleviate disease symptoms.

Dosage & Administration:

• Take exactly as prescribed by your hematologist.

• Usually taken twice daily with or without food.

• Swallow the tablet whole; do not crush, chew, or split.

• Regular blood tests are required to monitor blood counts and liver function.

Precautions:

• Inform your doctor if you have liver or kidney disease, infections, or low blood counts.

• Possible side effects include anemia, thrombocytopenia, bruising, dizziness, headache, or infections.

• Avoid live vaccines during treatment.

• Use effective contraception if pregnancy is possible.

• Store in a cool, dry place, away from light and moisture.

Why Choose Jakavi 5mg Tablet?

• Clinically proven JAK inhibitor

• Reduces spleen enlargement and disease symptoms

• Helps control blood counts effectively

• Trusted therapy for myeloproliferative disorders

Package Includes:

• Each pack contains 30 tablets of 5mg Jakavi (Ruxolitinib)